Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
React to this article
Latest news
Date Title
05:40p MARION ENERGY : Appointment of Voluntary Administrator
05:40p Strandline Resources Limited Quarterly Activities Report - 31 December 2014
05:37p STRANDLINE RESOURCES : ASX:STA) Quarterly Activities Report - 31 December 2014
05:35p WATERBERG COAL : Quarterly Cashflow Report
05:35p WATERBERG COAL : Quarterly Operations Report
05:26p UNITEDHEALTH : Project Sunshine and UnitedHealth Group Teamed Up During Celtics Game for Boston Pediatric Patients
05:25p THRACE PLASTICS : Announcement for the Purchase of Own Shares
05:21p FIRSTENERGY : Planning for Possible Icing Conditions in Northern New Jersey and Eastern Pennsylvania
05:18p Genel Energy to replace CFO Metherell with former JP Morgan banker -Sky News
05:16p NIPPON STEEL & SUMITOMO METAL : FEATURE: Plastic bottle recycling becomes symbol of Kitakyushu
Latest news
Advertisement
Hot News 
BANCO ESPIRITO SANTO : Drought woes spread to another Brazilian state
BERKELEY MINERAL RESOURCES : Obsidian IR
Gulf Resources Announced Finding of Natural Gas Resources Under Its Bromine Well in Sichuan Area
RAMBLER METALS & MINING : Implements Revised Plan at the Ming Copper-Gold Mine
UNISYS : posts 4Q profit
Most Read News
03:28p Obama targets foreign profits with tax proposal, Republicans skeptical
01/31 U.S. regulators recall 2.1 million vehicles in new air bag issue
04:36a PANASONIC : battle through pain barrier to claim Top League crown (Rugby)
01:19a GM and China’s SAIC to push into Indonesia with no-frills vans
01/31 Lafarge SA, Holcim near deal to sell $7 billion in assets to CRH - WSJ
Most recommended articles
05:18p Genel Energy to replace CFO Metherell with former JP Morgan banker -Sky News
04:26p MOODY : Justice Department probing Moody's for mortgage deal grades: WSJ
04:20pDJU.S. Treasury's Sanctions Czar Says Iran Needs Nuclear Deal for Economy
04:20pDJFORD MOTOR : Correction to Ford Prices in Russia Article
03:28p Obama targets foreign profits with tax proposal, Republicans skeptical
Dynamic quotes  
ON
| OFF